The Diagnostic and Prognostic Value of miR-200c in Gastric Cancer: A Meta-Analysis

الملخص EN

Background.

The role of miR-200c in gastric cancer remains controversial.

This study is aimed at clarifying the diagnostic and prognostic value of miR-200c in gastric cancer through a meta-analysis.

Methods.

A comprehensive literature search of PubMed, Embase, and Ovid library databases was conducted.

The studies included were those conducted before December 2017.

The sensitivity and specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under curve (AUC) were used to estimate the diagnostic value of miR-200c.

Meanwhile, the pooled hazard ratio (HR) was used to estimate the prognostic value of miR-200c.

Results.

For the diagnostic value of miR-200c, six studies that included 202 patients with gastric cancer and 250 normal controls were analyzed.

The sensitivity, specificity, PLR, NLR, DOR, and AUC were 0.74, 0.66, 2.20, 0.40, 5.34, and 0.75, respectively.

Subgroup analysis showed no significant difference in the type of the sample, method for testing miR-200c, and ethnicity among the patients.

Meanwhile, for the prognostic value of miR-200c, seven studies comprising 935 patients with gastric cancer were analyzed.

The pooled results showed that miR-200c expression was associated with overall survival (HR=2.19) and disease-free survival (HR=1.73), but not with progression-free survival (HR=1.64) in patients with gastric cancer.

There was no publication bias across the studies.

Conclusions.

Both serum and tissue miR-200c have moderate diagnostic accuracy in gastric cancer.

miR-200c could also be used as a valuable indicator for predicting the prognosis of gastric cancer patients.